RESISTANCE TO CISPLATIN AND ANALOGS - MECHANISMS AND POTENTIAL CLINICAL IMPLICATIONS

被引：110

作者：

DEGRAEFF, A

SLEBOS, RJC

RODENHUIS, S

机构：

[1] NETHERLANDS CANC INST, DIV EXPTL THERAPY, PLESMANLAAN 121, 1066 CX AMSTERDAM, NETHERLANDS

[2] NETHERLANDS CANC INST, DIV CLIN ONCOL, 1066 CX AMSTERDAM, NETHERLANDS

来源：

关键词：

D O I：

10.1007/BF00254240

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：325 / 332

页数：8

共 103 条

[51] KOHN KW, 1981, DNA REPAIR LABORATOR, V1, P379
[52] BINDING OF CIS-DICHLORODIAMMINE PLATINUM(II) TO METALLOTHIONEIN IN EHRLICH CELLS
KRAKER, A
SCHMIDT, J
KREZOSKI, S
PETERING, DH
[J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 130 (02) : 786 - 792
[53] KRAKER AJ, 1986, P AM ASSOC CANC RES, V27, P286
[54] KUPPEN PJK, 1987, 4TH P EUR C CLIN ONC, P81
[55] LAURENT G, 1981, CANCER RES, V41, P3347
[56] DRUGS 5 YEARS LATER - CISPLATIN
LOEHRER, PJ
EINHORN, LH
[J]. ANNALS OF INTERNAL MEDICINE, 1984, 100 (05) : 704 - 713
[57] MASUDA H, 1986, P AM ASSOC CANC RES, V27, P264
[58] MCVIE JG, 1984, ANTITUMOR DRUG RESIS, P39
[59] POSSIBLE MECHANISM FOR DIFFERENCES IN SENSITIVITY TO CISPLATINUM IN HUMAN-PROSTATE TUMOR-CELL LINES
METCALFE, SA
CAIN, K
HILL, BT
[J]. CANCER LETTERS, 1986, 31 (02) : 163 - 169
[60] MICETICH K, 1983, CANCER RES, V43, P3609